Colon-specific immune microenvironment regulates cancer progression versus rejection

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• Immunotherapies offer benefits for many cancers, but their efficacy in colorectal cancer (CRC) is limited to a subset of patients.
• Tissue-specific factors within the tumor microenvironment can hinder anti-tumor immunity, contributing to immunotherapy resistance.
• A deeper understanding of how the colon microenvironment shapes immune responses in CRC is crucial for developing new treatments.

Purpose of the Study:

• To investigate the role of the colon microenvironment in regulating immune responses to colorectal cancer (CRC).
• To identify immune signatures associated with tumor progression versus spontaneous rejection in an orthotopic CRC mouse model.
• To explore potential mechanisms of immunotherapy resistance in CRC.

Main Methods:

• Utilized an orthotopic MC38-CRC mouse model for studying tumor progression.
• Monitored tumor growth using bioluminescence imaging.
• Assessed immune signatures at transcriptional (NanoString) and cellular (flow cytometry) levels.

Main Results:

• A subset of mice (25-35%) developed progressive lethal CRC, while others spontaneously rejected tumors.
• Tumor rejection was dependent on adaptive immunity and orthotopic location.
• Progressive CRC tumors showed a protumor immune response (regulatory T-lymphocytes, suppressive myeloid cells).
• Tumor-rejecting mice exhibited an early inflammatory response and an antitumor microenvironment rich in CD8+ T cells.

Conclusions:

• The colon microenvironment plays a significant role in determining anti-tumor versus protumor immune responses in CRC.
• The identified immune signatures in the orthotopic model provide a basis for understanding immunotherapy response in colon cancer.
• This study highlights the importance of the orthotopic CRC model for investigating immune dynamics and therapeutic strategies.